摘要 |
Bicyclic fused benzenoid compounds of the formula <IMAGE> (I') and pharmaceutically acceptable cationic and acid addition salts thereof, where M is O, CH2 or NR6; R6 is hydrogen, formyl, carbobenzyloxy or certain carboalkoxyalkyl, alkanoyl, alkyl, aralkyl or aralkylcarbonyl groups; A' is: (1) A where one of A and B is hydrogen such that when A is hydrogen, B is C(R2R3)(CH2)fQ and f is 1 or 2; when B is hydrogen, A is C(R2R3)(CH2)fQ and f is 0 or 1, when taken together A and OR1 form a lactone or certain derivatives thereof; (2) A' is <IMAGE> (3) A' is Q3; Q is CO2R7, COR8, C(OH)R8R9, CN, CONR12R13, CH2NR12R13, CH2NHCOR14, CH2NHSO2R17 or 5-tetrazoyl; Q3 is <IMAGE> 5-tetrazolyl, CH2CONHCOR7, COOH or certain ester, amide, carboximido or sulfonimido derivatives thereof, CONHOH, CONHCONH2, or COCH2Q4 where Q4 is CN or COOH or certain esters thereof; R1 is hydrogen, benzyl or certain acyl groups; R4 is hydrogen, certain alkyl or certain aralkyl groups; R5 is hydrogen or certain alkyl groups; Z is (C1-C9)alkylene, optionally interrupted by O, S, SO or SO2; and W is hydrogen, methyl, certain aryl or cycloalkyl groups; useful in mammals as analgesics, tranquilizers, antiemetic agents, diuretics, anticonvulsants, antidiarrheals, antitussives, in treatment of glaucoma, and intermediates therefore.
|